Published in Clin Infect Dis on June 01, 2009
HIV in young men who have sex with men: a review of epidemiology, risk and protective factors, and interventions. J Sex Res (2011) 3.38
Comprehensive clinical care for men who have sex with men: an integrated approach. Lancet (2012) 1.65
Unprotected sex, underestimated risk, undiagnosed HIV and sexually transmitted diseases among men who have sex with men accessing testing services in a New England bathhouse. J Acquir Immune Defic Syndr (2012) 1.18
The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA. AIDS (2011) 1.14
Factors associated with refusal of rapid HIV testing in an emergency department. AIDS Behav (2011) 1.13
Counselor-based rapid HIV testing in community pharmacies. AIDS Patient Care STDS (2013) 1.06
Age cohort differences in the effects of gay-related stigma, anxiety and identification with the gay community on sexual risk and substance use. AIDS Behav (2013) 1.01
How "community" matters for how people interact with information: mixed methods study of young men who have sex with other men. J Med Internet Res (2013) 0.99
Sex parties among young gay, bisexual, and other men who have sex with men in New York City: attendance and behavior. J Urban Health (2011) 0.97
The Development and Implementation of an Outreach Program to Identify Acute and Recent HIV Infections in New York City. Open AIDS J (2010) 0.92
Short communication: Transmitted drug resistance and molecular epidemiology in antiretroviral naive HIV type 1-infected patients in Rhode Island. AIDS Res Hum Retroviruses (2010) 0.92
Implementing bathhouse-based voluntary counselling and testing has no adverse effect on bathhouse patronage among men who have sex with men. Int J STD AIDS (2012) 0.88
HIV-testing behavior and associated factors among MSM in Chongqing, China: results of 2 consecutive cross-sectional surveys from 2009 to 2010. Medicine (Baltimore) (2014) 0.84
HIV prevention in gay bathhouses and sex clubs across the United States. J Acquir Immune Defic Syndr (2010) 0.84
Partners met via sex parties present significantly greater odds for condomless anal sex among MSM: an event-level analysis of venues where male partners are met. J Acquir Immune Defic Syndr (2014) 0.81
Presence of an HIV Testing Program Lowers the Prevalence of Unprotected Insertive Anal Intercourse inside a Gay Bathhouse among HIV-negative and HIV-unknown Patrons. J HIV AIDS Soc Serv (2014) 0.79
Venues, patrons, and alcohol use dynamics: the creation of a high risk sexual environment. AIDS Behav (2014) 0.78
Gay bathhouse HIV prevention: the use of staff monitoring of patron sexual behavior. Sex Res Social Policy (2013) 0.75
Rapid HIV antibody testing among men who have sex with men who visited a gay bathhouse in Hangzhou, China: a cross-sectional study. BMJ Open (2015) 0.75
Differences and Similarities in HIV Testing Among Men Who have Sex with Men and Women (MSMW) and Men Who Have Sex with Men Only (MSMO). Open AIDS J (2012) 0.75
Bathhouse distribution of HIV self-testing kits reaches diverse, high-risk population. AIDS Care (2016) 0.75
Use of multiple sex venues and prevalence of HIV risk behavior: identifying high-risk men who have sex with men. Arch Sex Behav (2014) 0.75
Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst (1959) 94.48
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis (2005) 21.08
Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr (2005) 15.14
New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA (1998) 9.32
Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis (2004) 8.30
High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis (2007) 7.70
Detection of acute infections during HIV testing in North Carolina. N Engl J Med (2005) 7.60
HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men--five U.S. cities, June 2004-April 2005. MMWR Morb Mortal Wkly Rep (2005) 7.25
A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. J Homosex (2001) 3.80
HIV incidence among young men who have sex with men--seven U.S. cities, 1994-2000. MMWR Morb Mortal Wkly Rep (2001) 3.65
Barebacking among gay and bisexual men in New York City: explanations for the emergence of intentional unsafe behavior. Arch Sex Behav (2003) 2.62
Differential HIV risk in bathhouses and public cruising areas. Am J Public Health (2001) 2.49
Same-sex attraction disclosure to health care providers among New York City men who have sex with men: implications for HIV testing approaches. Arch Intern Med (2008) 2.22
The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient. J Infect Dis (2007) 1.93
Racial disparities in HIV incidence among young men who have sex with men: the Baltimore Young Men's Survey. J Acquir Immune Defic Syndr (2007) 1.68
Bathhouse-based voluntary counseling and testing is feasible and shows preliminary evidence of effectiveness. J Acquir Immune Defic Syndr (2006) 1.47
The differential infectivity and staged progression models for the transmission of HIV. Math Biosci (1999) 1.29
Modeling the impact of random screening and contact tracing in reducing the spread of HIV. Math Biosci (2003) 1.28
"There is such a thing as asking for trouble": taking rapid HIV testing to gay venues is fraught with challenges. Sex Transm Infect (2007) 1.27
Probability sample estimates of bathhouse sexual risk behavior. J Acquir Immune Defic Syndr (2007) 1.24
Unintentional HIV exposures from young men who have sex with men who disclose being HIV-negative. AIDS (2006) 1.24
HIV risk factors reported by two samples of male bathhouse attendees in Los Angeles, California, 2001-2002. Sex Transm Dis (2008) 1.21
Sexual behaviors in an urban bathhouse 15 years into the HIV epidemic. J Acquir Immune Defic Syndr (2002) 1.15
Designing an HIV counseling and testing program for bathhouses: the Seattle experience with strategies to improve acceptability. J Homosex (2003) 1.14
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet (2008) 19.65
Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults. Clin Infect Dis (2008) 4.47
Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a 7-month-old infant. JAMA (2002) 2.93
The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults. AIDS Res Hum Retroviruses (2002) 2.89
Evidence of dysregulation of dendritic cells in primary HIV infection. Blood (2010) 2.39
Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents. Lancet (2003) 2.04
Asthma is inversely associated with Helicobacter pylori status in an urban population. PLoS One (2008) 2.04
A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy. AIDS (2003) 1.99
Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy. J Infect Dis (2012) 1.98
HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial. J Acquir Immune Defic Syndr (2005) 1.87
ISCEV Standard for Clinical Electro-oculography (EOG) 2006. Doc Ophthalmol (2006) 1.60
Immunological memory after exposure to variola virus, monkeypox virus, and vaccinia virus. J Infect Dis (2007) 1.59
Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. J Infect Dis (2010) 1.52
Viewing pornography depicting unprotected anal intercourse: are there implications for HIV prevention among men who have sex with men? Arch Sex Behav (2011) 1.44
Healing of retinal photocoagulation lesions. Invest Ophthalmol Vis Sci (2008) 1.44
Awareness of post-exposure HIV prophylaxis in high-risk men who have sex with men in New York City. Sex Transm Infect (2011) 1.43
Ritonavir-based highly active antiretroviral therapy in human immunodeficiency virus type 1-infected infants younger than 24 months of age. Pediatr Infect Dis J (2005) 1.34
Beliefs about HIV non-infection and risky sexual behavior among MSM. AIDS Educ Prev (2004) 1.33
Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatr Infect Dis J (2006) 1.32
Using surveillance data to monitor entry into care of newly diagnosed HIV-infected persons: San Francisco, 2006-2007. BMC Public Health (2009) 1.29
Case-crossover study of partner and situational factors for unprotected sex. J Acquir Immune Defic Syndr (2002) 1.29
Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis. J Infect Dis (2004) 1.26
Extragenital gonorrhea and chlamydia testing and infection among men who have sex with men--STD Surveillance Network, United States, 2010-2012. Clin Infect Dis (2014) 1.25
HIV protease inhibitors inhibit the development of preerythrocytic-stage plasmodium parasites. J Infect Dis (2009) 1.24
Factors associated with insulin resistance among children and adolescents perinatally infected with HIV-1 in the pediatric HIV/AIDS cohort study. Horm Res Paediatr (2011) 1.23
Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects. J Infect Dis (2008) 1.22
HIV infection in rural villages of Cameroon. J Acquir Immune Defic Syndr (2002) 1.21
Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial. J Acquir Immune Defic Syndr (2004) 1.17
Human immunodeficiency virus (HIV) reverse transcriptase activity correlates with HIV RNA load: implications for resource-limited settings. J Clin Microbiol (2005) 1.14
Bone mineral density in children and adolescents with perinatal HIV infection. AIDS (2013) 1.13
Characteristics of a residential and working community with diverse exposure to World Trade Center dust, gas, and fumes. J Occup Environ Med (2009) 1.12
Mycobacterium tuberculosis-induced CXCR4 and chemokine expression leads to preferential X4 HIV-1 replication in human macrophages. J Immunol (2004) 1.11
A new trend in the HIV epidemic among men who have sex with men, San Francisco, 2004-2011. J Acquir Immune Defic Syndr (2013) 1.10
Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study. Am J Clin Nutr (2011) 1.08
Penetrating keratoplasty with pars plana glaucoma drainage devices. Cornea (2007) 1.08
The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine. AIDS (2006) 1.07
Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial. Clin Infect Dis (2010) 1.07
Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia. Blood (2008) 1.06
The ISNT rule and differentiation of normal from glaucomatous eyes. Arch Ophthalmol (2006) 1.06
A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults. Antivir Ther (2003) 1.02
Severe varicella caused by varicella-vaccine strain in a child with significant T-cell dysfunction. Pediatrics (2007) 1.02
Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy. J Infect Dis (2006) 1.01
Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy. Pediatrics (2007) 1.00
HIV treatments have malaria gametocyte killing and transmission blocking activity. J Infect Dis (2013) 0.99
CCR5 expression and duration of high risk sexual activity among HIV-seronegative men who have sex with men. AIDS (2006) 0.99
Distribution of CCR2-64I and SDF1-3'A alleles and HIV status in 7 ethnic populations of Cameroon. J Acquir Immune Defic Syndr (2005) 0.98
Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy. J Infect Dis (2009) 0.97
HIV nonnucleoside reverse transcriptase inhibitors and trimethoprim-sulfamethoxazole inhibit plasmodium liver stages. J Infect Dis (2012) 0.96
Comparative evaluation of refractive surgery candidates with Placido topography, Orbscan II, Pentacam, and wavefront analysis. J Cataract Refract Surg (2008) 0.96
Douching practices among women at high risk of HIV infection in the United States: implications for microbicide testing and use. Sex Transm Dis (2002) 0.95
Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment. AIDS (2013) 0.95
Monitoring virologic responses to antiretroviral therapy in HIV-infected adults in Kenya: evaluation of a low-cost viral load assay. PLoS One (2009) 0.93
Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248). J Acquir Immune Defic Syndr (2004) 0.93
The Development and Implementation of an Outreach Program to Identify Acute and Recent HIV Infections in New York City. Open AIDS J (2010) 0.92
Sexual risk behaviors, circumcision status, and preexisting immunity to adenovirus type 5 among men who have sex with men participating in a randomized HIV-1 vaccine efficacy trial: step study. J Acquir Immune Defic Syndr (2012) 0.92
Implementation of a validated peripheral neuropathy screening tool in patients receiving antiretroviral therapy in Mombasa, Kenya. Am J Trop Med Hyg (2010) 0.91
Migration of retinal cells through a perforated membrane: implications for a high-resolution prosthesis. Invest Ophthalmol Vis Sci (2004) 0.91
Increased gut microbial translocation in HIV-infected children persists in virologic responders and virologic failures after antiretroviral therapy. Pediatr Infect Dis J (2012) 0.90
Prevalence of genital warts among sexually transmitted disease clinic patients-sexually transmitted disease surveillance network, United States, January 2010 to December 2011. Sex Transm Dis (2014) 0.89
Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy. Vaccine (2013) 0.89
Neisseria gonorrhoeae strain with reduced susceptibilities to extended-spectrum cephalosporins. Emerg Infect Dis (2014) 0.89
Pharmacokinetics of high-dose lopinavir-ritonavir with and without saquinavir or nonnucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected pediatric and adolescent patients previously treated with protease inhibitors. Antimicrob Agents Chemother (2008) 0.89
Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy. J Infect Dis (2008) 0.88
Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307. AIDS Res Hum Retroviruses (2004) 0.88
HIV testing among patients infected with Neisseria gonorrhoeae: STD Surveillance Network, United States, 2009-2010. AIDS Behav (2013) 0.88
The effect of antiretrovirals on Plasmodium falciparum liver stages. AIDS (2013) 0.88
Condom use and male homosexual pornography. Am J Public Health (2009) 0.87
Growth patterns in pubertal HIV-infected adolescents and their correlation with cytokines, IGF-1, IGFBP-1, and IGFBP-3. J Pediatr Endocrinol Metab (2013) 0.86
Using the Neisseria gonorrhoeae multiantigen sequence-typing method to assess strain diversity and antibiotic resistance in San Francisco, California. Microb Drug Resist (2012) 0.86
The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection. J Infect Dis (2010) 0.85
HPV vaccine implementation in STD clinics--STD Surveillance Network. Sex Transm Dis (2012) 0.84
A reverse transcriptase assay for early diagnosis of infant HIV infection in resource-limited settings. J Trop Pediatr (2007) 0.84
Seroprevalence of Helicobacter pylori in New York City populations originating in East Asia. J Urban Health (2005) 0.84
FOXP3+Helios+ Regulatory T Cells, Immune Activation, and Advancing Disease in HIV-Infected Children. J Acquir Immune Defic Syndr (2016) 0.83
Immunoreconstitution in children receiving highly active antiretroviral therapy depends on the CD4 cell percentage at baseline. J Infect Dis (2002) 0.83
Developmental or degenerative--NR2E3 gene mutations in two patients with enhanced S cone syndrome. Mol Vis (2011) 0.83
Longitudinal spirometry among patients in a treatment program for community members with World Trade Center-related illness. J Occup Environ Med (2012) 0.82
Abnormal newborn screens and acylcarnitines in HIV-exposed and ARV-exposed infants. Pediatr Infect Dis J (2013) 0.82
HIV policy: the path forward--a joint position paper of the HIV Medicine Association of the Infectious Diseases Society of America and the American College of Physicians. Clin Infect Dis (2009) 0.82
Prevalence and significance of G6PD deficiency in patients of an urban HIV clinic. J Int Assoc Physicians AIDS Care (Chic) (2008) 0.81
Perinatal transmission and viral evolution of hepatitis C virus quasispecies in infants coinfected with HIV. J Acquir Immune Defic Syndr (2004) 0.81
Sexually transmitted infection related stigma and shame among African American male youth: implications for testing practices, partner notification, and treatment. AIDS Patient Care STDS (2014) 0.81
Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084. Am J Obstet Gynecol (2007) 0.81
Evaluation of a new point-of-care serologic assay for herpes simplex virus type 2 infection. Clin Infect Dis (2008) 0.80
Prevalence and correlates of herpes simplex virus type-2 infection among men who have sex with men, san francisco, 2008. Sex Transm Dis (2011) 0.80
Targeted ablation of perianal high-grade dysplasia in men who have sex with men: an alternative to mapping and wide local excision. Dis Colon Rectum (2015) 0.80